BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 17371267)

  • 1. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
    Keren-Paz A; Bercovich Z; Kahana C
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
    Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
    Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
    Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
    Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor.
    Kahana C
    Essays Biochem; 2009 Nov; 46():47-61. PubMed ID: 20095969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
    Nilsson J; Grahn B; Heby O
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.
    Keren-Paz A; Bercovich Z; Porat Z; Erez O; Brener O; Kahana C
    Oncogene; 2006 Aug; 25(37):5163-72. PubMed ID: 16568078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antizyme 3 inhibits polyamine uptake and ornithine decarboxylase (ODC) activity, but does not stimulate ODC degradation.
    Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
    Biochem J; 2009 Apr; 419(1):99-103, 1 p following 103. PubMed ID: 19076071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated.
    Gritli-Linde A; Nilsson J; Bohlooly-Y M; Heby O; Linde A
    Dev Dyn; 2001 Mar; 220(3):259-75. PubMed ID: 11241834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of all members of the antizyme family by antizyme inhibitor.
    Mangold U; Leberer E
    Biochem J; 2005 Jan; 385(Pt 1):21-8. PubMed ID: 15355308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial cell proliferation: regulation of cellular polyamines.
    Morrison RF; Seidel ER
    Cardiovasc Res; 1995 Jun; 29(6):841-7. PubMed ID: 7656288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of ornithine decarboxylase by the 26S proteasome.
    Murakami Y; Matsufuji S; Hayashi S; Tanahashi N; Tanaka K
    Biochem Biophys Res Commun; 2000 Jan; 267(1):1-6. PubMed ID: 10623564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism.
    Kim SW; Mangold U; Waghorne C; Mobascher A; Shantz L; Banyard J; Zetter BR
    J Cell Sci; 2006 Jun; 119(Pt 12):2583-91. PubMed ID: 16735445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
    Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
    J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of antizyme-mediated regulation of polyamine homeostasis.
    Wu HY; Chen SF; Hsieh JY; Chou F; Wang YH; Lin WT; Lee PY; Yu YJ; Lin LY; Lin TS; Lin CL; Liu GY; Tzeng SR; Hung HC; Chan NL
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11229-34. PubMed ID: 26305948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased translation efficiency and antizyme-dependent stabilization of ornithine decarboxylase in amino acid-supplemented human colon adenocarcinoma cells, Caco-2.
    Chabanon H; Persson L; Wallace HM; Ferrara M; Brachet P
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):401-8. PubMed ID: 10816435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ornithine decarboxylase antizyme: a novel type of regulatory protein.
    Hayashi S; Murakami Y; Matsufuji S
    Trends Biochem Sci; 1996 Jan; 21(1):27-30. PubMed ID: 8848835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of a polyamine transporter regulated by antizyme.
    Sakata K; Kashiwagi K; Igarashi K
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):297-303. PubMed ID: 10727431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyamine analogs with xylene rings induce antizyme frameshifting, reduce ODC activity, and deplete cellular polyamines.
    Petros LM; Graminski GF; Robinson S; Burns MR; Kisiel N; Gesteland RF; Atkins JF; Kramer DL; Howard MT; Weeks RS
    J Biochem; 2006 Nov; 140(5):657-66. PubMed ID: 16998202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamines regulate their synthesis by inducing expression and blocking degradation of ODC antizyme.
    Palanimurugan R; Scheel H; Hofmann K; Dohmen RJ
    EMBO J; 2004 Dec; 23(24):4857-67. PubMed ID: 15538383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein degradation, the main hub in the regulation of cellular polyamines.
    Kahana C
    Biochem J; 2016 Dec; 473(24):4551-4558. PubMed ID: 27941031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.